19 results on '"van Gelder, T"'
Search Results
2. Reply to the letter to the editor ‘Potential clinical relevant drug–drug interactions: comparison between different compendia, do we have a validated method?’ by Conde-Estévez et al.
3. Drug–drug interactions in patients treated for cancer: a prospective study on clinical interventions†
4. 205P Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifen
5. Effects of dietary restriction in cancer patients receiving irinotecan
6. Influence of cow’s milk on the absorption and exposure of erlotinib in NSCLC patients
7. Influence of the proton pump inhibitor esomeprazole on the bioavailability of regorafenib
8. Toxicity and efficacy of flat-dosed versus body-surface area (BSA)-dosed capecitabine
9. 1913P - Effects of dietary restriction in cancer patients receiving irinotecan
10. 1540P - Influence of cow’s milk on the absorption and exposure of erlotinib in NSCLC patients
11. 473P - Influence of the proton pump inhibitor esomeprazole on the bioavailability of regorafenib
12. 527P - Toxicity and efficacy of flat-dosed versus body-surface area (BSA)-dosed capecitabine
13. Drug-Drug Interactions in Patients Treated for Cancer: a Prospective Study on Clinical Interventions
14. First Intra-Patient Comparison of Antidepressant Use Among Tamoxifen Patients
15. Concomitant Use of Antidepressant Drugs and Tamoxifen
16. Drug Interactions in Cancer Patients Treated with Oral Anti-Cancer Drugs
17. 484P - Drug-Drug Interactions in Patients Treated for Cancer: a Prospective Study on Clinical Interventions
18. 322P - First Intra-Patient Comparison of Antidepressant Use Among Tamoxifen Patients
19. Potential clinical relevant drug-drug interactions: comparison between different compendia, do we have a validated method?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.